Welcome to our dedicated page for ASE Technology SEC filings (Ticker: ASX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ASE Technology Holding Co., Ltd. (ASX) SEC filings page provides access to the company’s U.S. regulatory disclosures, primarily furnished on Form 6-K as a foreign private issuer and supplemented by its annual report on Form 20-F. These documents offer detailed insight into ASE Technology Holding’s semiconductor assembly, testing and electronic manufacturing services operations.
In its Form 6-K earnings releases, ASE Technology Holding reports consolidated financial results, including total net revenues, cost of revenues, gross profit, operating income, non-operating items, income before tax and net income attributable to shareholders of the parent. The filings break out revenues from packaging operations, testing operations, EMS operations and others, and provide segment-level metrics for ATM (assembly, testing and material) and EMS, such as gross margin, operating margin and equipment capital expenditures.
Additional 6-K filings present monthly net revenue data for both consolidated operations and ATM assembly, testing and material business, in New Taiwan dollars and U.S. dollars. These filings show sequential and year-over-year percentage changes and summarize quarterly and full-year net revenues, giving investors a granular view of revenue trends.
ASE Technology Holding’s filings also disclose application and product-type breakdowns for ATM and EMS, customer concentration information, geographic footprint, liquidity indicators, unused credit lines, current ratio, net debt to equity ratio and employee counts. Safe Harbor Notices in the filings outline risk factors and forward-looking statement language, while references to the Form 20-F direct readers to more comprehensive annual disclosures.
On this page, Stock Titan surfaces these SEC filings with AI-powered summaries that highlight key figures, segment performance and notable disclosures, helping users quickly understand the main points of each 6-K or 20-F without reading every table. Investors can use this resource to follow ASE Technology Holding’s reported financial performance, segment evolution and risk disclosures over time.
ASE Technology Holding Co., Ltd. reported revised unaudited consolidated net revenues for July 2025 of NT$51,542 million (US$1,769 million). Consolidated revenue rose 4.1% sequentially in NT$ and 6.5% sequentially in US$, while July was essentially flat year-over-year in NT$ (-0.1% YoY) but up 11.2% YoY in US$ versus July 2024. The assembly, testing and materials (ATM) segment generated NT$31,783 million (US$1,091 million), up 3.6% sequentially and 15.8% YoY in NT$ (29.0% YoY in US$). The company notes these figures are revised and unaudited and provided to meet Taiwan regulatory requirements.
ASE Technology (ASX) – Form 6-K, Q2 2025 results. Consolidated revenue reached NT$150.8 bn (+2 % QoQ, +7 % YoY), driven by the core ATM business, which climbed 20 % YoY to NT$91.6 bn and now represents 61 % of sales. EMS declined 7 % YoY to NT$58.4 bn.
Group gross profit improved to NT$25.7 bn with a 17.0 % margin (+20 bp QoQ, +60 bp YoY). Operating income grew 5 % QoQ to NT$10.2 bn (6.8 % margin). Nevertheless, pretax income fell 8 % YoY and net income attributable to shareholders slipped 3 % YoY to NT$7.5 bn; basic EPS was NT$1.74.
Within ATM, testing revenue surged 32 % YoY; leading-edge packaging & testing exceeded 10 % of ATM sales versus 6 % for FY-24. Segment gross margin remained robust at 21.9 % despite a 70 bp sequential easing. EMS margin stayed low at 2.6 % and operating profit dropped 22 % YoY.
Balance sheet: cash fell to NT$72.8 bn while interest-bearing debt rose to NT$240.1 bn, lifting net-debt/equity from 0.41 to 0.52. Capex totaled US$992 m in Q2, outpacing quarterly EBITDA (US$879 m).
Guidance: Management expects Q3 2025 USD revenue to rise 12-14 % QoQ (ATM +9-11 %, EMS +18-20 %), but projects a 1.0-1.2 pp gross-margin decline and a 0.1-0.3 pp operating-margin decline. EMS margin should improve 0.3-0.5 pp.